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Abstract The rat Cu/Zn Superoxide dismutase (SOD1) is 
expressed in all tissues. Sequence analysis of the SOD1 promoter 
region showed that none of the ««-elements of hepatocyte-
specific nuclear factors (HNF) were observed. The «'«-element of 
C/ΕΒΡα in the proximal region of the SOD1 promoter and the 
high level of C/ΕΒΡα in the liver tissue led us to focus on the 
transcriptional regulation of the SOD1 gene by C/EBPa. 
Cotransfection assays with the plasmid expressing transcription 
factor C/ΕΒΡα showed that C/ΕΒΡα transactivated SOD1 gene 
by 27 fold. The marked transactivation and direct binding of C/ 
EBPa to the SOD1 promoter were confirmed by deletion 
analyses and mobility shift assays. These results suggested that 
C/ΕΒΡα plays a major role in the tissue distribution of SOD1. 
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1. Introduction 
The Cu/Zn Superoxide dismutase (SOD1) is a key enzyme 
in the metabolism of oxygen free radicals. It catalyzes the 
dismutation of Superoxide radicals (0^~) to oxygen and hydro-
gen peroxide [1]. The production and/or removal of Superox-
ides has been observed to play a significant role in a variety of 
critical homeostatic mechanisms both at the cellular and at 
the organismic level. It has been reported that SOD1 can 
prevent oncogenesis and tumor promotion [2]; reduce the cy-
totoxic and cardiotoxic effects of anticancer drugs [3]; protect 
against reperfusion damage of ischemic tissue [4]. Recently, it 
has been shown that overexpression of SOD 1 and catalase can 
increase the average life span of flies [5]. 
It is known that SOD1 is expressed in all tissues at varying 
levels. In particular kidney and liver show the highest Cu/Zn 
SOD mRNA levels [6]. This distribution is consistent with the 
relative protein concentration and activity of SOD1 in these 
tissues [7]. There are four known major factor families ex-
pressed in the liver: C/EBP (CCAAT/enhancer-binding pro-
tein), HNF-1, HNF-3 and HNF-4 [8]. Members of these pro-
tein families are expressed in embryonic liver as well as in the 
adult. Since sequence analysis of the SOD1 promoter region 
showed none of the c«-elements of hepatocyte-specific nuclear 
factors, we performed the deletion experiment to focus the 
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most influential cw-element in this promoter. We report here 
that the transcription factor C/ΕΒΡα, which is expressed at 
high levels in liver and adipose tissue, influenced the expres-
sion of SOD1 gene most. 
2. Materials and methods 
2.1. Plasmid construction 
The 1.7 kb BamHI/Smal fragment (nt -1633 to +85) from the rat 
SOD1 gene [9] was inserted into pBLCAT3 [10]. Unidirectional 5' 
deletion mutants were produced by cutting 5' region of the SOD1 
promoter with Sphl and BamHI, followed by treatment with exonu-
clease III [11]. The end points of deletion were confirmed by DNA 
sequencing with Sequenase kit (US Biochemicals). Plasmid pMSV-C/ 
EBPa was a generous gift from S.L. McKnight. For the construction 
of pGEX3XC/EBPcx, the expression plasmid of the GST-C/ΕΒΡα fu-
sion protein, the BamHI fragment of pMSV-C/ΕΒΡα was inserted 
into the BamHI site of pGEX3X (Pharmacia). 
2.2. Cell culture and transfection 
Human HepG2 hepatoma cells were grown in Dulbecco's modified 
Eagle's medium (DMEM)/10% fetal calf serum/penicillin G sodium at 
100 units per ml/streptomycin sulfate at 100 μg per ml/amphotericin B 
at 250 ng per ml. Cells were seeded into 60 mm plastic culture dishes 
(30-50% confluence) for 24 h prior to transfection. Equal amounts 
(3.0 pmol) of the various constructs were transfected to the cells by 
the calcium phosphate DNA coprecipitation method [12]. 5 μg of 
pRSVß-gal plasmid [13] was introduced in all experiments to correct 
the variations of transfection efficiency. The effector plasmid was co-
transfected to test for transacting activities. To determine the effective 
concentration of effector plasmid, cells were cotransfected with report-
er plasmid and various amounts of effector plasmid. 
2.3. CAT assay 
The CAT assay was performed as described previously [14]. The 
transfected cells were washed twice with PBS and harvested. The 
pelleted cells were resuspended in 100 μΐ of 0.25 M Tris-HCl (pH 
7.9) and lysed by three cycles of freezing and thawing. After removal 
of cell debris by centrifugation, cell extracts were first assayed for β-
galactosidase activity [15]. Equal quantities of proteins were assayed 
for CAT activity on the basis of ß-galactosidase activity. Extracts 
were incubated with 0.025 μθϊ of [14C]chloramphenicol/0.25 M Tris-
HCl pH 7.6/0.4 mM acetyl coenzyme A for 1 h at 37°C. The enzyme 
assay was terminated by adding ethylacetate. The organic layer was 
analyzed by thin layer chromatography (TLC) with chloroform/ 
methanol (95:5). After autoradiography, both acetylated and unace-
tylated forms of [14C]chloramphenicol were scraped from the plate 
and the conversion of chloramphenicol to the acetylated form was 
calculated by measuring radioactivity. The relative CAT activities 
were calculated from the percent conversion. Results are the average 
of three independent experiments. 
2.4. Mobility shift assay 
The synthetic oligonucleotides for the transcription factor CP2 
binding site were purchased from Genosys. [γ-32Ρ]ΑΤΡ and [a-
32P]dATP were from Amersham. The double-stranded oligonucleotide 
was labeled with [γ-32Ρ]ΑΤΡ and polynucleotide kinase [15]. Purified 
GST-C/ΕΒΡα was mixed with CP2 oligonucleotide for 20 min at 20°C 
in 15 μΐ solution containing 10 mM HEPES, 100 mM KC1, 5 mM 
MgCl2, 1 mM dithiothreitol, 1 mM EDTA, 10% glycerol, and 2 μg of 
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poly[dI-dC]. The binding reaction mixtures were electrophoresed in 
6% acrylamide gels in 0.5XTBE (44 mM Tris, 44 mM boric acid, 
and 1 mM EDTA). After electrophoresis, gels were dried and exposed 
to X-ray film. For competition assays, binding reaction was per-
formed with a 50-fold molar excess of cold probe or competitor 
DNA. Nuclear extracts from HepG2 cells were made as described 
previously [16]. 
2.5. Purification of CIEBPa 
pGEX3XC/EBPa was introduced in E. coli BL21(DE3). To express 
soluble fusion proteins, overnight cultures of cells were diluted with 10 
volumes of induction medium (3.2% bacto-tryptone, 2% yeast extract, 
0.1 mM MgS04, 1 mM FeCl3, 1 ΧΜ9 salt), cultured for an additional 
2 h, and induced with 1 mM isopropyl ß-D-thiogalactopyranoside 
(IPTG; Sigma) at 37°C for 2 h. Cells from 3 ml of culture were 
harvested and resuspended in 0.5 ml of phosphate-buffered saline 
(PBS) containing 1% Triton X-100 (PBS-Triton). The lysates were 
sonicated three times with 15-s pulses, and the debris was pelleted 
by centrifugation. 10 μΐ of supernatant was mixed with 50 μΐ of glu-
tathione-Sepharose (Sigma), equilibrated and suspended in PBS-Tri-
ton according to the manufacturer's specification, and incubated at 
4°C for 30 min. The Sepharose was collected by centrifugation, 
washed three times with PBS-Triton, resuspended in 10 μΐ of sodium 
dodecyl sulfate (SDS) sample loading buffer (50 mM Tris-HCl [pH 
6.8], 2% SDS, 100 mM dithiothreitol, 0.1% bromophenol blue, 10% 
glycerol), and assayed by SDS-polyacrylamide gel electrophoresis 
(PAGE). 
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Fig. 2. Activation of expression of the SOD1 gene by C/ΕΒΡα. De-
letion mutants were cotransfected with pMSV-C/ΕΒΡα, effector 
plasmid (1.6 μg). When cotransfected with pMSV-C/ΕΒΡα, the 
CAT activities of pRSP-412, pRSP-305 and pRSP-74 were dramati-
cally increased. The solid bar and open bar represent the CAT ac-
tivity of SOD-CAT fusion plasmid cotransfected without and with 
effector plasmid, respectively. 
3. Results and discussion 
3.1. Identification of CIEBPa binding site in SOD1 promoter 
As shown in Fig. 1, from the sequence analysis of transcrip-
tion factor binding sites, the sites for CAAT box binding 
protein (CP2) and NF-IL6 were located at - 7 3 and - 1 0 1 , 
respectively. Interestingly, none of the HNF series (HNF-1, 3, 
and 4) was observed in the promoter region of rat SOD1 gene. 
C/ΕΒΡα and NF-IL6 (LAP; liver activator protein) are mem-
bers of a bZIP protein subfamily since they share 71% homol-
ogy in their basic DNA binding region and leucine zipper 
region, and they have been shown to form heterodimers 
[17]. The CP2 site has a CCAAT motif which could also be 
bound by C/EBPa. 
-412 
TGGAGATAGAACATGGGCCTTACACATATTACACCGAGCATCCATCTTGG 
- 3 6 2 
CTCACCCCAACTTTCACACAGCAACTGCGGCGCGCTGCAAAGTCAGTCGC 
- 3 1 2 
AATCCGCATnCTAGACAGAGCGGCnCAGACCTTCCAGGCGCGCACGCA 
- 2 6 2 
GGCCTCGCCGAGGnTCCTCCGCGACTCGGCCGACTTCACAGTTAGAAGA 
- 2 1 2 
CAATAGCGACTTTCCCAGCTCTGTCTCGATTCTGGAACTnCTCAGTCGC 
- 1 6 2 
AAGCTCCTGAAGCTGGCGCTCCCCTCAGCCCCGCCCCCAACGTGCCCCGC 
- 1 1 2 AP2 
GGCCAGGGAACTTCAGGAAGGGTAGGCAGAGACCGCGGCTAGCGlATTGGir 
-62 N F - I L 6 CP2 
TCCCTGCCAAGGTGGGAGTGGCCAGGCACAGGCATATAAAAGCTCCGCGG 
-12 TBP +1 f tsp 
CGCTGGGCCCTCGTTTTGCACCTTCGTTTCCTGCGGCGGCTTCTGTCGTC 
+39 
TCCTTGCTTTTTGCTCTCCCAGGnCCGAGGCCGCCGCGCGTCTCCCGGG 
+89 
GAAGCATG 
MET 
Fig. 1. Sequence analysis of the rat SOD1 promoter. The sequence 
is shown from —412 to +96 relative to the transcription start point 
(tsp). Transcription factor binding sites for AP2, NF-IL6, CP2 and 
TBP are underlined. The CCAAT box is in a box. 
A series of 5' deletion mutants was prepared to determine 
whether the SOD1 promoter might harbor cis-elements criti-
cal for transactivation by C/ΕΒΡα. In addition to pRSP-412, 
deletion mutants terminating at positions —305, —74 and —55 
were tested by transient expression experiments (Fig. 2). Each 
deletion mutant was cotransfected into HepG2 cells with 1.6 
μg of pMSV-C/ΕΒΡα plasmid. When the expression was ex-
amined in the absence of pMSV-C/ΕΒΡα, the level of expres-
sion of all constructs was very low with a slight difference. As 
shown in Fig. 2, a substantially higher level of SOD1 promo-
ter activity was maintained at least —74 bp upstream from the 
transcription start point (tsp). When the expression was ex-
amined in the presence of pMSV-C/ΕΒΡα, the level of expres-
sion of three constructs was dramatically increased. But the 
level of expression of pRSP-55 was not changed. The induc-
tion fold of pRSP-412 was higher than any other constructs 
by cotransfection of the pMSV-C/ΕΒΡα plasmid. 
These results show that C/ΕΒΡα can activate the transcrip-
tion of the SOD1 promoter when expressed in transiently 
transfected HepG2 cells. It is known that the SOD1 promoter 
contains a canonical NF-IL6 site (—101), and a CP2 site 
(—73) (Fig. 1). At least these sites may be responsible for 
the transactivation by C/ΕΒΡα. van Ooij et al. [18] reported 
that C/EBPa and NF-IL6 did appear to have a synergistic 
effect on the ADH gene family. C/ΕΒΡα and NF-IL6 hetero-
dimers are more effective than either C/EBP homodimers or 
NF-IL6 homodimers. In the case of the SOD1 promoter, the 
differential responses to C/ΕΒΡα may be physiologically sig-
nificant for the interaction with other factors during liver 
development and/or adipocyte differentiation. 
3.2. C/EBPa activates the transcription of SOD 1 
To test whether C/EBP might be capable of regulation of 
the SOD1 gene, a chimeric SOD-CAT gene was cotransfected 
into HepG2 cells along with the C/EBP expression vector, 
pMSV-C/ΕΒΡα. Friedman et al. [19] previously reported 
that the HepG2 cell line appeared to exhibit substantially 
lower levels of C/ΕΒΡα than other liver-derived hepatocytes. 
The SOD-CAT chimera contained nucleotides -412 to +85 
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fused to the CAT structural gene. This construct was trans-
fected by the calcium phosphate method into HepG2 together 
with either pUC19 DNA as a control or increasing amounts 
of pMSV-C/ΕΒΡα DNA. As shown in Fig. 3, the SOD pro-
moter of pRSP-412 was strongly transactivated by C/EBPa. 
The amount of C/ΕΒΡα expression plasmid (1.6 μg) was still 
in the range of a linear increase of the transcriptional activity 
of target gene. However, the transcriptional activity was 
slightly, but reproducibly reduced when cotransfected with a 
larger amount of C/ΕΒΡα expression plasmid (Fig. 3). It has 
been reported that in at least two different systems, overex-
pression of a transcriptional activator may cause inhibition of 
transcription [20]. In this case, overexpressed C/ΕΒΡα in 
HepG2 cell may have a squelching effect on the expression 
of the SOD1 promoter. 
C/ΕΒΡα is expressed at high levels in liver and adipose 
tissue [21] and is important for the expression of the liver-
specific genes as well as several adipose-specific genes. It is 
possible that C/ΕΒΡα plays a role in conferring both the tis-
sue-specific and developmental properties of the SOD1 gene. 
Because SOD1 is expressed at relatively high levels in kidney, 
the SOD1 level is unlikely to be mediated only by C/ΕΒΡα. C/ 
EBPa is one of several factors that regulate SOD1 gene tran-
scription. The LAP, also known as NF-IL6, site was located 
at -101 in the SOD1 promoter. This protein may bind to or 
A 
SOD promoter 
pRSP-412 , 1 — | CAT | 
-412 
MSV LTR 
pMSV-C/ΕΒΡα i 1 C/EBPa | 
B 
30 | 1 
>> T 
■+J A -i-
"> 2 5 - / —T——_T 
-*-3 / J_ 
< 20 - y 
< 15 - / 
& 5 
0.0 0.8 1.6 2.4 3.2 
pMSV-C/EBPa(Ag) 
Fig. 3. Determination of an effective concentration of the effector 
plasmid. A: Schematic diagram of pRSP-412 and pMSV-C/EBPa, 
the expression vector of the C/EBP gene. B: pMSV-C/EBPa, the ef-
fector plasmid was cotransfected with pRSP-412, a SOD1-CAT fu-
sion plasmid, in order to check the effective concentration. The 
maximal CAT activity was shown at the point of about 1.6 μg of 
effector plasmid. 
Fig. 4. Direct binding of C/ΕΒΡα to the CAAT box sequence of the 
rat SOD1 promoter. A 32P-labeled double-stranded oligonucleotide 
corresponding to the CP2 site (-74 to -55 region in the SOD1 
promoter) was incubated with 100 ng of C/ΕΒΡα expressed in E. 
coli. In order to express C/EBPa protein in E. coli, a GST-C/EBPa 
fusion plasmid was constructed as described in Section 2. Purified 
GST-C/ΕΒΡα was subjected to MSA reaction mixture. The C/EBPa 
consensus oligonucleotide and AP2 consensus oligonucleotide were 
used as specific and non-specific competitor, respectively. The C/ 
ΕΒΡα-DNA complex is indicated by a solid arrowhead. 
form a heterodimer with the C/ΕΒΡα to stimulate transcrip-
tion from the SOD1 promoter. 
3.3. Direct binding of C/EBPa to the CP2 site of the SOD1 
gene 
As shown in Fig. 2, the target sequence for C/ΕΒΡα was 
located in the - 7 4 to - 5 5 region. We therefore tested the 
direct binding activity of C/ΕΒΡα to this site by mobility shift 
assay (MSA). In order to express C/ΕΒΡα protein, GST-C/ 
EBPa fusion plasmid was constructed. The expressed GST-C/ 
EBPa in E. coli was purified as described in Section 2. We 
used double-stranded oligonucleotide corresponding to the 
CP2 site ( -74 to - 5 5 region) in the SOD1 promoter. 100 
ng of GST-C/ΕΒΡα protein expressed in E. coli was used in 
the MSA. In Fig. 4, a specific C/EBPa-DNA complex was 
observed in contrast to the control experiment. The specific 
DNA-protein complex disappeared when the C/ΕΒΡα consen-
sus oligonucleotide was added to the reaction mixture. When 
the AP2 consensus oligonucleotide was used as a non-specific 
competitor, the specific C/EBPa-DNA complex was not af-
fected. This result shows that a functional C/ΕΒΡα binding 
site was located in the CP2 site of the SOD1 promoter and C/ 
EBPa activated the transcription of the rat SOD1 gene 
through direct binding. 
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